Skip to Content
If you were attending the recent FDA gathering of expert scientists, orthopaedic device developers, and surgeons who implant total hip replacements (THR), you would leave believing that the issue of early failures and metal toxicity from artificial hips was a new development. But a closer look at science from the […]
Author: Cal Warriner
It used to be that the arms industry was the bad boy of all industries. Move over! Big Pharma has now topped the gun trade with a $3 billion fine imposed on GlaxoSmithKline (GSK). Britain’s largest pharmaceutical company, GSK, was just busted for offering lavish incentives to doctors to promote […]
On July 4, 2012, Stryker posted on its website a national recall of its Rejuvenate and ADM hip implant systems. It’s obvious that Stryker has received far too many reports of shockingly premature failures of its hip implant. The Rejuvenate has only been on the market since 2009 so enough […]
Documents recently posted to the FDA’s website say pharmaceutical company, Amylin, has not been completely forthcoming about its diabetes drug, Byetta, and related drug Bydureon, concerning their potential for cardiovascular complications. The active ingredient is the same in the two drugs which are both used to treat type 2 diabetes. However, Bydureon […]
The Searcy Denney Mass Tort Unit would like to thank our client, Howard Sadwin of Sarasota, Florida, for his poignant statements today before the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee for the Food and Drug Administration. The hearings were convened in Gaithersburg, Maryland. In addition […]
As a Stryker hip implant attorney, I have written previously about our experience with clients who had Stryker hip replacement problems. Most of these clients tell us about conversations with their doctors before surgery in which they were told the Rejuvenate hip was better for them due to their young […]
According to an analysis by the Institute for Safe Medication Practices, Pradaxa drug (Dabigatran) topped the list of direct reports to the FDA for serious adverse drug events in 2011. Pradaxa took the lead with 817 direct reports, followed by Coumadin (Warfarin) with 490 direct reports, Levaquin (Levofloxacin) with 393, […]
It seems sort of nonsensical to blame the victim for his or her condition but that is what medical device maker Stryker appears to be doing in an April Field Safety Notice (FSN). In the United Kingdom, medical device manufacturers are required to report to the MHRA, their version of our […]
Even though more than 93,000 patients have been implanted with the now recalled DePuy metal-on-metal hip, the U.S. Food and Drug Administration wants to start a conversation. It seems a little like the proverbial “closing the barn door after the horse has already escaped”. The federal agency will convene a […]
According to a study published June 11, the users of Actos (pioglitazone) or Avandia (rosiglitazone) may face an increased risk of developing macular edema. Published in the Archives of Internal Medicine, British researchers collected data on more than 100,000 patients with type 2 diabetes who were enrolled in the British […]
